# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The study has identified a potentially new drug formulation that could potentially extend the period of remission and prevent r...
Silo Pharma, Inc. (NASDAQ: SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company foc...
SPC-14 shows cognitive and stress reduction benefits in preclinical models SARASOTA, FL, April 10, 2024 (GLOBE NEWSWIRE) -- Si...
The Dow Jones index closed lower by around 10 points on Monday. When insiders purchase or sell shares, it indicates their confi...